MicroPort CRM

company

About

MicroPort CRM develops solutions for the management of cardiac rhythm disorders and heart failure.

  • 251 - 500

Details

Last Funding Type
Series C
Last Funding Money Raised
$150M
Industries
CRM,Health Care,Health Diagnostics,Medical,Medical Device
Founded date
Jan 1, 2017
Number Of Employee
251 - 500
Operating Status
Active

MicroPort® CRM is a pioneering company in the field of Cardiac Rhythm Management (CRM), and a subsidiary of MicroPort® Scientific Corporation (stock code: 00853.HK), with world headquarters in Clamart, just outside Paris, France. Through its long-standing expertise in CRM, MicroPort® CRM develops, manufactures and markets around the world cardiac pacemakers, implantable cardiac defibrillators, cardiac resynchronization systems and ECG diagnostic solutions for the management of cardiac rhythm disorders and heart failure. Its state-of-the-art products are manufactured in Clamart, France, Saluggia, Italy, Santo Domingo, Dominican Republic, and Shanghai, China.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$150M
MicroPort CRM has raised a total of $150M in funding over 2 rounds. Their latest funding was raised on Jul 26, 2021 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 26, 2021 Series C $150M 2 Detail

Investments

Number of Investments
Number of Lead Investments
2
0
MicroPort CRM has made 2 investments. Their most recent investment was on Jun 30, 2021, when Loopi raised $5M.
Date Company Name
Round Money Raised Industry Lead Investor
Jun 30, 2021 Loopi
Seed $5M Apps
May 18, 2021 Pebble Health
Series Unknown $5.09M Health Care

Investors

Number of Lead Investors
Number of Investors
2
MicroPort CRM is funded by 2 investors. Wanhai Investment and Yongrong Asset are the most recent investors.
Investor Name Lead Investor Funding Round
Wanhai Investment Series C
Yongrong Asset Series C